Regression of liver metastases after treatment with intraperitoneal catumaxomab for malignant ascites due to breast cancer

Author： Petrelli Fausto   Borgonovo Karen   Lonati Veronica   Elia Stefano   Barni Sandro  

Publisher： Springer Publishing Company

ISSN： 1776-2596

Source： Targeted Oncology, Vol.8, Iss.4, 2013-12, pp. : 291-294

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The trifunctional antibody catumaxomab in treatment of malignant ascites and peritoneal carcinomatosis

By Ströhlein Michael A   Heiss Markus M  

Future Oncology, Vol. 6, Iss. 9, 2010-09 ,pp. : 1387-1394

Future Medicine

Access to resources Recommend Favorite

Liver insufficiency due to breast cancer metastases

By Henry Stéphanie   Machiels Jean-Pascal   Baurain Jean-François   Duck Lionel  

Acta Oncologica, Vol. 43, Iss. 3, 2004-04 ,pp. : 302-302

Informa Healthcare

Access to resources Recommend Favorite

B ultrasound-guided hyperthermic intraperitoneal perfusion chemotherapy for the treatment of malignant ascites

By                  

Oncology Reports, Vol. 28, Iss. 4, 2012-01 ,pp. : 1325-1331

Spandidos Publications

Access to resources Recommend Favorite

Salvage Gastrectomy After Intravenous and Intraperitoneal Paclitaxel (PTX) Administration with Oral S-1 for Peritoneal Dissemination of Advanced Gastric Cancer with Malignant Ascites

By Kitayama Joji   Ishigami Hironori   Yamaguchi Hironori   Yamashita Hiroharu   Emoto Shigenobu   Kaisaki Shoich   Watanabe Toshiaki  

Annals of Surgical Oncology, Vol. 21, Iss. 2, 2014-02 ,pp. : 539-546

Springer Publishing Company

Access to resources Recommend Favorite

Hepatic Resection for Liver Metastases as Part of the “Oncosurgical” Treatment of Metastatic Breast Cancer

By Caralt Mireia  

Annals of Surgical Oncology, Vol. 15, Iss. 10, 2008-10 ,pp. : 2804-2810

Springer Publishing Company

Access to resources Recommend Favorite